Milrinone Lactate Injection, Solution
Product Images NDC 0409-0212

This is a description of a medication provided in a 10mL bottle with NDC 0409-0212-10. Each mL of the medication contains milrinone lactate and is equivalent to 1mg of milrinone and 47mg of anhydrous dextrose in water for injection. The pH of the injection is adjusted between 3.2 and 4.0 with lactic acid and/or sodium hydroxide. The medication should be stored at 20-25°C (68 to 77°F) and should not be frozen. It does not contain a preservative. The medication is for intravenous use only and is manufactured by Glnd Phama Limited and Hospira, Inc.*

Milrinone Lactate Injection is a medication used for intravenous administration. Each vial contains 10 mg of Milrinone and 47 mg of Dextrose Anhydrous, which is mixed with water for injection. The pH is adjusted with Lactic acid and/or Sodium Hydroxide. The total concentration of active ingredient can vary between 10.55 mg/mL and 129 mg/mL. The recommended storage temperature is between 20°C to 25°C. The unused portion should be discarded after initial use. The dosage instructions are available in the package insert. The medicine is manufactured by G Pharms Limited and does not contain any preservatives. Each single-dose vial contains 10 mL of solution and has an NDC of 0409-0212-1.*

This is a description of a single-dose vial containing 20 mg/20 mL of Milrinone Lactate Injection, intended for intravenous use only. Each milliliter of the injection contains milrinone lactate equivalent to 1 mg of milrinone and 47 mg of dextrose. The pH of the injection is adjusted with lactic acid and/or sodium hydroxide and it should be stored at a controlled room temperature between 20-25°C (68-77°F). This product is manufactured by Gland Pharma Limited in Hyderabad, India and is available under the label of Hospira, Inc. with the NDC 0409-0212-11. The details of the lot number and expiration date are not available.*

This appears to be a product label/insert for Milrinone Lactate Injection, with dosage information and directions for use. It is intended for intravenous use only and includes a warning to use only as directed by a healthcare professional. It also includes the manufacturer name Hospira and the National Drug Code (NDC) 0409021211, which can be used for identification.*

Milrinone Lactate Injection is a medication for intravenous use only, contained in a single-dose vial with a concentration of 50mg/50mL. It contains milrinone, dextrose, water, acidic substances, and sodium hydroxide, but does not contain a preservative. The pH is adjusted to between 3.2 and 4.0 using acidic substances or sodium hydroxide. The usual dosage is provided in the package insert, and the medication should be stored at controlled room temperature and not frozen. This product is manufactured by Gland Pharma Limited located in Hyderabad, India, and is manufactured for Hospira, Inc. in Illinois, USA. The lot and BP number are not available.*

This is a product description for Milrinone Lactate Injection, available in two concentrations of 50mg/50ml, 150mg/50ml. This injection is for intravenous use only and contains Milrinone compound, sodium, and water. It is manufactured by Hospira, a subsidiary of Pfizer, and can be stored at 25°C. The instruction label on the package contains dosage information and expiry date. This text seems like a scanned image and contains errors.*